Management of risk factors for accelerated atherosclerosis

Current Treatment Options in Neurology

Volumn 11, Issue 6, 2009, Pages 460-472

  Song, Sarah ^a   Ovbiagele, Bruce ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATORVASTATIN; CISAPRIDE; CLARITHROMYCIN; CLOPIDOGREL; COLESTYRAMINE; CYCLOSPORIN; DIAZOXIDE; DIGITALIS; DIGITALIS GLYCOSIDE; DOFETILIDE; FIBRIC ACID DERIVATIVE; GOLD; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LITHIUM SALT; LOSARTAN; NONSTEROID ANTIINFLAMMATORY AGENT; PERINDOPRIL; PLACEBO; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT; RETINOIC ACID; SIMVASTATIN; SODIUM DIHYDROGEN PHOSPHATE; TELMISARTAN; UNINDEXED DRUG;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ALKALOSIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANOREXIA; ARTERY DISEASE; ATHEROSCLEROSIS; BACKACHE; BLEEDING; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COUGHING; CRANIAL NERVE INJURY; DIARRHEA; DIET RESTRICTION; DIZZINESS; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG POTENTIATION; EDEMA; ENTEROPATHY; FATIGUE; FLUSHING; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEAD AND NECK TUMOR; HEART INFARCTION; HEART PALPITATION; HEARTBURN; HEMATOMA; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; IRRITABILITY; LIFESTYLE MODIFICATION; LOADING DRUG DOSE; MONOTHERAPY; MUSCLE CRAMP; MYOPATHY; NAUSEA; NOSE CONGESTION; ORTHOSTATIC HYPOTENSION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSICAL ACTIVITY; POSTOPERATIVE CARE; PREGNANCY; RECURRENT DISEASE; RESTENOSIS; REVIEW; RHABDOMYOLYSIS; RHINITIS; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SEIZURE; SIDE EFFECT; SINUSITIS; SMOKING CESSATION; STENOSIS; STENT; STOMACH PAIN; STROKE; TINNITUS; UPPER RESPIRATORY TRACT INFECTION;

EID: 70350154971     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-009-0050-4     Document Type: Review

References (37)

1. Munger MA, HEwkins DW: Atherothrombosis: epidemiology, pathophysiology, and prevention. J Am Pharm Assoc 2004, 44:S5-S12.
2. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126
3. Sacco RL, Adams R, Albers G, et al.: Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke. Stroke 2006, 37:577-617.
4. Lloyd-Jones D, Adams R, Carnethon M, et al.: Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:480-486.
5. Coull A, Lovett JK, Rothwell PM: Population based study of early risk of stroke after transient ischaemic attack or minor stroke: Implications for public education and organisation of services. BMJ 2004, 328:326.
6. Kleindorfer D, Panagos P, Pancioli A, et al.: Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke 2005, 36:720-723.
7. Johnston S, Gress DR, Browner WS, Sidney S: Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000, 284:2901-2906.
8. Hankey G: Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis 2003, 16(Suppl 1):14-19.
9. Hardie K, Hankey GJ, Jamrozik K, et al.: Ten-year survival after first-ever stroke in the Perth community stroke study. Stroke 2003, 34:1842-1846.
10. Rothwell PM, Giles MF, Chandratheva A, et al.: Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): A prospective population-based sequential comparison. Lancet 2007, 370:1432-1442.
11. Rashid P, Leonardi-Bee J, Bath P: Blood pressure reduction and secondary prevention of stroke and other vascular events: A systemic review. Stroke 2003, 34:2741-2748.
12. Post-stroke antihypertensive treatment study. A preliminary result. PATS Collaborating Group. Chin Med J (Engl) 1995, 108:710-717.
13. PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6 105 individuals with previous stroke or transient ischaemic attack. Lancet 2001, 358:1033-1041.
14. Yusuf S, Diener HC, Sacco RL, et al.: Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 2008, 359:1225-1237.
15. Physician's Desk Reference, edn 57. New York: Thomson Healthcare; 2002.
16. Rx List. Available at http://www.rxlist.com. Last accessed on September 3, 2009.
17. Heart Protection Study Collaborative Group: Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004, 363:757-767.
18. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006, 355:549-559.
19. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324:71-86.
20. CAPRIE Steering Committee: A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996, 348:1329-1339.
21. Diener HC, Bogousslavsky J, Brass LM, et al.: Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomized, double-blind, placebocontrolled trial. Lancet 2004, 364:331-337.
22. Bhatt DL, Fox KAA, Hacke W, et al.: Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006, 354:1706-1717.
23. Diener HC, Cunha L, Forbes C, et al.: European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996, 143:1-13.
24. ESPRIT Study Group, Halkes PH, van Gijn J, et al.: Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): Randomized controlled trial. Lancet 2006, 367:1665-1673.
25. Sacco RL, Diener HC, Yusuf S, et al.: Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008, 359:1238-1251.
26. The American Siabetes Association: Executive summary: standards of medical care in diabetes-2009. Diabetes Care 2009, 32:S6-S12.
27. Drexel H, Aczel S, Marte T, et al.: Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol? Diabetes Care 2005, 28:101-107.
28. Wilcox R, Bousser MG, Betteridge DJ: Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: Results from PROactive (PROspective pioglitAzone Clinical Trial in macroVascular Events 04). Stroke 2007, 38:65-73.
29. Shinton R, Beevers G: Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989, 298:789-794.
30. North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med 1991, 325:445-453.
31. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study: Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995, 273:1421-1428.
32. Halliday A, Mansfield A, Marro J, et al.: Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomized controlled trial. Lancet 2004, 363:1491-1502.
33. Gray WA, White HJ Jr, Barrett DM, et al.: Carotid stenting and endarterectomy: A clinical and cost comparison of revascularization strategies. Stroke 2002, 33:1063-1070.
34. Nussbaum ES, Heros RC, Erickson DL, et al.: Cost-effectiveness of carotid endarterectomy. Neurosurgery 1996, 38:237-244.
35. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): A randomised trial. Lancet 2001, 357:1729-1737.
36. Yadav JS, Wholey MH, Kuntz RE, et al.: Protected carotidartery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004, 351:1493-1501.
37. Eckstein HH, Ringleb P, Allenberg JR, et al.: Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenosis at 2 years: A multinational, prospective, randomized trial. Lancet Neurol 2008, 7:893-902.